Sofinnova Investments, Inc. Apellis Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $1.28 Million - $1.67 Million	-49,580 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.47 - $18.71 $5.74 Million - $9.36 Million	-500,000 Reduced 90.98%	49,580 $654,000
Q3 2018 Nov 15, 2018	SELL	$16.57 - $21.03 $1.1 Million - $1.39 Million	-66,222 Reduced 10.75%	549,580 $9.77 Million
Q2 2018 Aug 14, 2018	SELL	$19.63 - $30.0 $5.81 Million - $8.88 Million	-295,950 Reduced 32.46%	615,802 $13.5 Million
Q1 2018 May 15, 2018	BUY	$14.01 - $26.02 $12.8 Million - $23.7 Million	911,752 New	911,752 $20.2 Million

309

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.79B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.